medicina61巻6号

2024年05月発行

特集 睡眠にまつわる疑問にすべて答えます！—あなたの患者の睡眠中に何かが起きているかもしれない 各科で見かける睡眠関連疾患

内科疾患と睡眠関連疾患—見逃されがちな両者の関わり

著者： 茶谷裕¹

所属機関： ¹ちゃたに脳神経すいみんクリニック

ページ範囲：P.920 - P.924

Point
◎睡眠呼吸異常症（SDB）は，メジャーな内科疾患である高血圧症，糖尿病，慢性腎臓病（CKD）の発症や増悪に関係がある．
◎SDBは高尿酸血症や胃食道逆流症（GERD），二次性多血症とも関連がある．
◎レストレスレッグズ症候群（RLS）はフェリチン低下と関連する．
◎小児のRLSの症状は，成人の典型例とは異なっていたり，低年齢では適切に症状を説明できない可能性があったりするため，注意が必要である．

参考文献

1）Benjafield AV, et al：Estimation of the global prevalence and burden of obstructive sleep apnoea；A literature based analysis. Lancet Respir Med 7：687-698, 2019 PMID 31300334

2）Broström A, et al：Factors associated with undiagnosed obstructive sleep apnoea in hypertensive primary care patients. Scand J Prim Health Care 30：107-113, 2012 PMID 22643156

3）Mohsenin V, et al：The effect of gender on the prevalence of hypertension in obstructive sleep apnea. Sleep Med 10：759-762, 2009 PMID 19185538

4）Ono A, et al：Factors relating to inadequate control of blood pressure in hypertensive outpatients. Hypertens Res 26：219-224, 2003 PMID 12675255

5）日本循環器学会，他：2023年改訂版 循環器領域における睡眠呼吸障害の診断・治療に関するガイドライン．2023　https://www.j-circ.or.jp/cms/wp-content/uploads/2023/03/JCS2023_kasai.pdf（2023年12月閲覧）

6）Kario K, et al：Obstructive sleep apnea-induced neurogenic nocturnal hypertension；A potential role of renal denervation? Hypertension 77：1047-1060, 2021 PMID 33641363

7）Sasaki N, et al：Associations between characteristics of obstructive sleep apnea and nocturnal blood pressure surge. Hypertension 72：1133-1140, 2018 PMID 30354806

8）Eguchi K, et al：Nocturnal hypoxia is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population. Am J Hypertens 18：1489-1495, 2005 PMID 16280287

9）Kario K：Obstructive sleep apnea syndrome and hypertension；Ambulatory blood pressure. Hypertens Res 32：438-432, 2009 PMID 19494815

10）Kario K：Obstructive sleep apnea syndrome and hypertension；Mechanism of the linkage and 24-h blood pressure control. Hypertens Res 32：537-541, 2009 PMID 19461649

11）Calhoun DA, et al：Resistant hypertension；Diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 51：1403-1419, 2008 PMID 18391085

12）Umemura S, et al：The Japanese Society of Hypertension Guidelines for the Management of Hypertension（JSH 2019）. Hypertens Res 42：1235-1481, 2019 PMID 31375757

13）Kario K：Essential Manual of 24-hour Blood Pressure Management；From Morning to Nocturnal Hypertension, 2nd ed, pp1-374, Wiley-Blackwell, Hoboken, 2022

14）Hoshide S, et al：Characteristics of hypertension in obstructive sleep apnea；An Asian experience. J Clin Hypertens（Greenwich）23：489-495, 2021 PMID 33705599

15）Reutrakul S, Mokhlesi B：Obstructive sleep apnea and diabetes；A state of the art review. Chest 152：1070-1086, 2017 PMID 28527878

16）Adderley NJ, et al：Obstructive sleep apnea, a risk factor for cardiovascular and microvascular disease in patients with type 2 diabetes；Findings from a population-based cohort study. Diabetes Care 43：1868-1877, 2020 PMID 32345651

17）Brownlee M：The pathobiology of diabetic complications；A unifying mechanism. Diabetes 54：1615-1625, 2005 PMID 15919781

18）Yamauchi M, et al：Oxidative stress in obstructive sleep apnea. Chest 127：1674-1679, 2005 PMID 15888845

19）Tahrani AA, et al：Obstructive sleep apnea and diabetic neuropathy；A novel association in patients with type 2 diabetes. Am J Respir Crit Med 186：434-441, 2012 PMID 22723291

20）Tasbakan MS, et al：Positive airway pressure（PAP）treatment reduces glycated hemoglobin（HbA1c）levels in obstructive sleep apnea patients with concomitant weight loss；Longitudinal data from the ESADA. J Sleep Res 30：e13331, 2021 PMID 33987873

21）Lin CH, et al：Sleep apnea and chronic kidney disease；A state-of-the-art review. Chest 157：673-685, 2020 PMID 30099353

22）Nicholl DDM, et al：Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest 141：1422-1430, 2012 PMID 22222188

23）Ahmed SB, et al：Nocturnal hypoxia and loss of kidney function. PLoS One 6：e 19029, 2011 PMID 21559506

24）Matsumoto T, et al：Microalbuminuria in patients with obstructive sleep apnea-chronic obstructive pulmonary disease overlap syndrome. Ann Am Thorac Soc 13：917-925, 2016 PMID 26966922

25）Marrone O, et al：Fixed but not autoadjusting positive airway pressure attenuates the time-dependent decline in glomerular filtration rate in patients with OSA. Chest 154：326-334, 2018 PMID 29698721

26）Yang XH, et al：Association of sleep disorders, chronic pain, and fatigue with survival in patients with chronic kidney disease；A meta-analysis of clinical trials. Sleep Med 51：59-65, 2018 PMID 30099353

27）Rimke AN, et al：Effect of CPAP therapy on kidney function in patients with chronic kidney disease；A pilot randomized controlled trial. Chest 159：2008- 2019, 2021 PMID 33316238

28）加藤雅彦：睡眠時無呼吸症候群と痛風，高尿酸血症．痛風と核酸代謝36：145-146, 2012

29）Yanagihara K, et al：Nasal continuous positive airway pressure and serum uric acid levels in patients with obstructive sleep apnea. J Yonago Med 59：65-173, 2008

30）Prudon B, et al：Serum urate levels are unchanged with continuous positive airway pressure therapy for obstructive sleep apnea；A randomized controlled trial. Sleep Med 14：1419-1421, 2013 PMID 24152796

31）Wan YF, et al：Uric acid levels in obstructive sleep apnea patients with atrial fibrillation. Arch Med Res 45：132-137, 2014 PMID 24316394

32）Wu ZH, et al：The relationship between obstructive sleep apnea syndrome and gastroesophageal reflux disease；A meta-analysis. Sleep Breath 23：389-397, 2019 PMID 29987514

33）Emilsson, et al；Nocturnal gastroesophageal reflux, lung function and symptoms of obstructive sleep apnea；Results from an epidemiological survey. Respir Med 106：459-466, 2012 PMID 22197048

34）Shepherd KL, et al：Gastro-oesophageal reflux symptoms are related to the presence and severity of obstructive sleep apnea. J Sleep Res 20：241-249, 2011 PMID 20545839

35）日本消化器病学会（編）：胃食道逆流症（GERD）診療ガイドライン2021（改訂第3版），南江堂，2021

36）Allen RP, et al：Restless legs syndrome/Willis-Ekbom disease diagnostic criteria；Updated International Restless Legs Syndrome Study Group（IRLSSG）consensus criteria-history, rationale, description, and significance. Sleep Med 15：860-873, 2014 PMID 25023924

37）Picchietti DL, et al：Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and location. Sleep Med Rev 22：64-77, 2015 PMID 25553600

38）Venkateshiah SB, Ioachimescu OC：Restless legs syndrome. Crit Care Clin 31：459-472, 2015 PMID 26118915

39）Picchietti DL, et al：Restless legs syndrome；Prevalence and impact in children and adolescents-the Peds REST study. Pediatrics 120：253-266, 2007 PMID 17671050

40）Picchietti MA, Picchietti DL：Advance in pediatric restless legs syndrome；Iron, genetics, diagnosis and treatment. Sleep Med 11：643-651, 2010 PMID 20620105

41）Garcia-Borreguero D, et al：Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation；A combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med 21：1-11, 2016 PMID 27448465

42）McMullin MF, et al：A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline.Br J Haematol 184：176-191, 2019 PMID 30478826